nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Tamoxifen—pancreatic cancer	0.0733	0.203	CbGbCtD
Oxymorphone—CYP2D6—Erlotinib—pancreatic cancer	0.0624	0.173	CbGbCtD
Oxymorphone—CYP3A4—Tamoxifen—pancreatic cancer	0.0466	0.129	CbGbCtD
Oxymorphone—CYP3A4—Erlotinib—pancreatic cancer	0.0397	0.11	CbGbCtD
Oxymorphone—CYP3A4—Irinotecan—pancreatic cancer	0.0358	0.0993	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—pancreatic cancer	0.0308	0.0853	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—pancreatic cancer	0.0262	0.0728	CbGbCtD
Oxymorphone—CYP3A4—Sunitinib—pancreatic cancer	0.0261	0.0725	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—pancreatic cancer	0.0196	0.0543	CbGbCtD
Oxymorphone—Eye disorder—Docetaxel—pancreatic cancer	0.00074	0.00178	CcSEcCtD
Oxymorphone—Insomnia—Irinotecan—pancreatic cancer	0.000736	0.00177	CcSEcCtD
Oxymorphone—Flushing—Docetaxel—pancreatic cancer	0.000735	0.00177	CcSEcCtD
Oxymorphone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000735	0.00177	CcSEcCtD
Oxymorphone—Vomiting—Tamoxifen—pancreatic cancer	0.000734	0.00177	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—pancreatic cancer	0.000729	0.00176	CcSEcCtD
Oxymorphone—Hypotension—Fluorouracil—pancreatic cancer	0.000729	0.00175	CcSEcCtD
Oxymorphone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000728	0.00175	CcSEcCtD
Oxymorphone—Dermatitis—Tamoxifen—pancreatic cancer	0.000727	0.00175	CcSEcCtD
Oxymorphone—Vomiting—Erlotinib—pancreatic cancer	0.000726	0.00175	CcSEcCtD
Oxymorphone—Dyspnoea—Irinotecan—pancreatic cancer	0.000726	0.00175	CcSEcCtD
Oxymorphone—Somnolence—Irinotecan—pancreatic cancer	0.000724	0.00174	CcSEcCtD
Oxymorphone—Headache—Tamoxifen—pancreatic cancer	0.000723	0.00174	CcSEcCtD
Oxymorphone—Dermatitis—Erlotinib—pancreatic cancer	0.000719	0.00173	CcSEcCtD
Oxymorphone—Angiopathy—Docetaxel—pancreatic cancer	0.000719	0.00173	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—pancreatic cancer	0.000718	0.00173	CcSEcCtD
Oxymorphone—Insomnia—Gemcitabine—pancreatic cancer	0.000717	0.00173	CcSEcCtD
Oxymorphone—Dyspepsia—Irinotecan—pancreatic cancer	0.000717	0.00172	CcSEcCtD
Oxymorphone—Immune system disorder—Docetaxel—pancreatic cancer	0.000716	0.00172	CcSEcCtD
Oxymorphone—Headache—Erlotinib—pancreatic cancer	0.000715	0.00172	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—pancreatic cancer	0.000715	0.00172	CcSEcCtD
Oxymorphone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000714	0.00172	CcSEcCtD
Oxymorphone—Asthenia—Sunitinib—pancreatic cancer	0.000709	0.00171	CcSEcCtD
Oxymorphone—Decreased appetite—Irinotecan—pancreatic cancer	0.000708	0.0017	CcSEcCtD
Oxymorphone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000707	0.0017	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000705	0.0017	CcSEcCtD
Oxymorphone—Insomnia—Fluorouracil—pancreatic cancer	0.000705	0.0017	CcSEcCtD
Oxymorphone—Somnolence—Gemcitabine—pancreatic cancer	0.000705	0.0017	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000703	0.00169	CcSEcCtD
Oxymorphone—Fatigue—Irinotecan—pancreatic cancer	0.000702	0.00169	CcSEcCtD
Oxymorphone—Pruritus—Sunitinib—pancreatic cancer	0.000699	0.00168	CcSEcCtD
Oxymorphone—Pain—Irinotecan—pancreatic cancer	0.000696	0.00168	CcSEcCtD
Oxymorphone—Constipation—Irinotecan—pancreatic cancer	0.000696	0.00168	CcSEcCtD
Oxymorphone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000695	0.00167	CcSEcCtD
Oxymorphone—Mental disorder—Docetaxel—pancreatic cancer	0.000694	0.00167	CcSEcCtD
Oxymorphone—Somnolence—Fluorouracil—pancreatic cancer	0.000693	0.00167	CcSEcCtD
Oxymorphone—Malnutrition—Docetaxel—pancreatic cancer	0.00069	0.00166	CcSEcCtD
Oxymorphone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000689	0.00166	CcSEcCtD
Oxymorphone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000686	0.00165	CcSEcCtD
Oxymorphone—Nausea—Tamoxifen—pancreatic cancer	0.000685	0.00165	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000685	0.00165	CcSEcCtD
Oxymorphone—Fatigue—Gemcitabine—pancreatic cancer	0.000684	0.00165	CcSEcCtD
Oxymorphone—Pain—Gemcitabine—pancreatic cancer	0.000678	0.00163	CcSEcCtD
Oxymorphone—Constipation—Gemcitabine—pancreatic cancer	0.000678	0.00163	CcSEcCtD
Oxymorphone—Nausea—Erlotinib—pancreatic cancer	0.000678	0.00163	CcSEcCtD
Oxymorphone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000678	0.00163	CcSEcCtD
Oxymorphone—Diarrhoea—Sunitinib—pancreatic cancer	0.000676	0.00163	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000673	0.00162	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—pancreatic cancer	0.000672	0.00162	CcSEcCtD
Oxymorphone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000671	0.00161	CcSEcCtD
Oxymorphone—Pain—Fluorouracil—pancreatic cancer	0.000667	0.0016	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000666	0.0016	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—pancreatic cancer	0.000665	0.0016	CcSEcCtD
Oxymorphone—Dizziness—Sunitinib—pancreatic cancer	0.000654	0.00157	CcSEcCtD
Oxymorphone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000654	0.00157	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000653	0.00157	CcSEcCtD
Oxymorphone—Abdominal pain—Irinotecan—pancreatic cancer	0.000644	0.00155	CcSEcCtD
Oxymorphone—Body temperature increased—Irinotecan—pancreatic cancer	0.000644	0.00155	CcSEcCtD
Oxymorphone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000643	0.00155	CcSEcCtD
Oxymorphone—Vomiting—Sunitinib—pancreatic cancer	0.000628	0.00151	CcSEcCtD
Oxymorphone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000627	0.00151	CcSEcCtD
Oxymorphone—Dermatitis—Sunitinib—pancreatic cancer	0.000623	0.0015	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—pancreatic cancer	0.000622	0.0015	CcSEcCtD
Oxymorphone—Urticaria—Fluorouracil—pancreatic cancer	0.000619	0.00149	CcSEcCtD
Oxymorphone—Headache—Sunitinib—pancreatic cancer	0.000619	0.00149	CcSEcCtD
Oxymorphone—Syncope—Docetaxel—pancreatic cancer	0.000618	0.00149	CcSEcCtD
Oxymorphone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000616	0.00148	CcSEcCtD
Oxymorphone—Palpitations—Docetaxel—pancreatic cancer	0.000609	0.00147	CcSEcCtD
Oxymorphone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000606	0.00146	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—pancreatic cancer	0.000604	0.00145	CcSEcCtD
Oxymorphone—Hypersensitivity—Irinotecan—pancreatic cancer	0.0006	0.00144	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—pancreatic cancer	0.000599	0.00144	CcSEcCtD
Oxymorphone—Convulsion—Docetaxel—pancreatic cancer	0.000597	0.00144	CcSEcCtD
Oxymorphone—Hypertension—Docetaxel—pancreatic cancer	0.000595	0.00143	CcSEcCtD
Oxymorphone—Chest pain—Docetaxel—pancreatic cancer	0.000587	0.00141	CcSEcCtD
Oxymorphone—Nausea—Sunitinib—pancreatic cancer	0.000587	0.00141	CcSEcCtD
Oxymorphone—Asthenia—Irinotecan—pancreatic cancer	0.000584	0.00141	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000583	0.0014	CcSEcCtD
Oxymorphone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000574	0.00138	CcSEcCtD
Oxymorphone—Dry mouth—Docetaxel—pancreatic cancer	0.000574	0.00138	CcSEcCtD
Oxymorphone—Asthenia—Gemcitabine—pancreatic cancer	0.000569	0.00137	CcSEcCtD
Oxymorphone—Confusional state—Docetaxel—pancreatic cancer	0.000567	0.00137	CcSEcCtD
Oxymorphone—Oedema—Docetaxel—pancreatic cancer	0.000563	0.00135	CcSEcCtD
Oxymorphone—Pruritus—Gemcitabine—pancreatic cancer	0.000561	0.00135	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—pancreatic cancer	0.000559	0.00134	CcSEcCtD
Oxymorphone—Diarrhoea—Irinotecan—pancreatic cancer	0.000557	0.00134	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—pancreatic cancer	0.000554	0.00133	CcSEcCtD
Oxymorphone—Shock—Docetaxel—pancreatic cancer	0.000554	0.00133	CcSEcCtD
Oxymorphone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000552	0.00133	CcSEcCtD
Oxymorphone—Pruritus—Fluorouracil—pancreatic cancer	0.000552	0.00133	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—pancreatic cancer	0.000549	0.00132	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—pancreatic cancer	0.000547	0.00132	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—pancreatic cancer	0.000544	0.00131	CcSEcCtD
Oxymorphone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000543	0.00131	CcSEcCtD
Oxymorphone—Dizziness—Irinotecan—pancreatic cancer	0.000538	0.0013	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—pancreatic cancer	0.000536	0.00129	CcSEcCtD
Oxymorphone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000534	0.00128	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000528	0.00127	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—pancreatic cancer	0.000526	0.00127	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—pancreatic cancer	0.000524	0.00126	CcSEcCtD
Oxymorphone—Vomiting—Irinotecan—pancreatic cancer	0.000518	0.00125	CcSEcCtD
Oxymorphone—Dizziness—Fluorouracil—pancreatic cancer	0.000516	0.00124	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—pancreatic cancer	0.000515	0.00124	CcSEcCtD
Oxymorphone—Dermatitis—Irinotecan—pancreatic cancer	0.000513	0.00123	CcSEcCtD
Oxymorphone—Headache—Irinotecan—pancreatic cancer	0.00051	0.00123	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—pancreatic cancer	0.000509	0.00123	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—pancreatic cancer	0.000504	0.00121	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—pancreatic cancer	0.000503	0.00121	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—pancreatic cancer	0.000502	0.00121	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—pancreatic cancer	0.0005	0.0012	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—pancreatic cancer	0.0005	0.0012	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—pancreatic cancer	0.000499	0.0012	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—pancreatic cancer	0.000497	0.0012	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000496	0.00119	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—pancreatic cancer	0.000496	0.00119	CcSEcCtD
Oxymorphone—Vomiting—Fluorouracil—pancreatic cancer	0.000496	0.00119	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—pancreatic cancer	0.000495	0.00119	CcSEcCtD
Oxymorphone—Dermatitis—Fluorouracil—pancreatic cancer	0.000491	0.00118	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—pancreatic cancer	0.000489	0.00118	CcSEcCtD
Oxymorphone—Headache—Fluorouracil—pancreatic cancer	0.000488	0.00118	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000488	0.00117	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000486	0.00117	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—pancreatic cancer	0.000485	0.00117	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—pancreatic cancer	0.000485	0.00117	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000485	0.00117	CcSEcCtD
Oxymorphone—Nausea—Irinotecan—pancreatic cancer	0.000484	0.00116	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—pancreatic cancer	0.000483	0.00116	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000482	0.00116	CcSEcCtD
Oxymorphone—Constipation—Docetaxel—pancreatic cancer	0.000481	0.00116	CcSEcCtD
Oxymorphone—Pain—Docetaxel—pancreatic cancer	0.000481	0.00116	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—pancreatic cancer	0.000476	0.00115	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—pancreatic cancer	0.000471	0.00113	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—pancreatic cancer	0.000468	0.00113	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—pancreatic cancer	0.000465	0.00112	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000464	0.00112	CcSEcCtD
Oxymorphone—Nausea—Fluorouracil—pancreatic cancer	0.000463	0.00111	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—pancreatic cancer	0.000462	0.00111	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00046	0.00111	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—pancreatic cancer	0.000459	0.0011	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000459	0.0011	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—pancreatic cancer	0.000458	0.0011	CcSEcCtD
Oxymorphone—Tension—Epirubicin—pancreatic cancer	0.000456	0.0011	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—pancreatic cancer	0.000452	0.00109	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—pancreatic cancer	0.000449	0.00108	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000447	0.00107	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000446	0.00107	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—pancreatic cancer	0.000445	0.00107	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—pancreatic cancer	0.000445	0.00107	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—pancreatic cancer	0.000438	0.00105	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—pancreatic cancer	0.000433	0.00104	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—pancreatic cancer	0.00043	0.00104	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—pancreatic cancer	0.000427	0.00103	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—pancreatic cancer	0.000424	0.00102	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—pancreatic cancer	0.000422	0.00102	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—pancreatic cancer	0.000418	0.00101	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—pancreatic cancer	0.000418	0.00101	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—pancreatic cancer	0.000417	0.001	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000415	0.000998	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—pancreatic cancer	0.000411	0.000989	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000409	0.000984	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—pancreatic cancer	0.000406	0.000976	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—pancreatic cancer	0.000404	0.000972	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—pancreatic cancer	0.000403	0.00097	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—pancreatic cancer	0.000402	0.000966	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—pancreatic cancer	0.000398	0.000958	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—pancreatic cancer	0.000396	0.000953	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—pancreatic cancer	0.000395	0.000952	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—pancreatic cancer	0.000395	0.00095	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000393	0.000946	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—pancreatic cancer	0.000387	0.000932	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—pancreatic cancer	0.000387	0.000931	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—pancreatic cancer	0.000386	0.000929	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—pancreatic cancer	0.000385	0.000927	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—pancreatic cancer	0.000383	0.000921	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—pancreatic cancer	0.00038	0.000915	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—pancreatic cancer	0.00038	0.000914	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000378	0.00091	CcSEcCtD
Oxymorphone—Shock—Epirubicin—pancreatic cancer	0.000373	0.000899	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—pancreatic cancer	0.000373	0.000897	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000372	0.000896	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—pancreatic cancer	0.000372	0.000896	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—pancreatic cancer	0.000372	0.000894	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—pancreatic cancer	0.00037	0.000892	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—pancreatic cancer	0.000369	0.000887	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000367	0.000883	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—pancreatic cancer	0.000366	0.000882	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—pancreatic cancer	0.000365	0.000879	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000364	0.000876	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—pancreatic cancer	0.000362	0.000871	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—pancreatic cancer	0.000358	0.000862	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—pancreatic cancer	0.000358	0.000861	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—pancreatic cancer	0.000355	0.000854	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—pancreatic cancer	0.000355	0.000853	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—pancreatic cancer	0.000354	0.000852	CcSEcCtD
Oxymorphone—Headache—Docetaxel—pancreatic cancer	0.000353	0.000849	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—pancreatic cancer	0.000351	0.000845	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—pancreatic cancer	0.000346	0.000832	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000344	0.000829	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—pancreatic cancer	0.000343	0.000826	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—pancreatic cancer	0.000343	0.000825	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—pancreatic cancer	0.000341	0.000821	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00034	0.000817	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—pancreatic cancer	0.000338	0.000814	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—pancreatic cancer	0.000337	0.000812	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—pancreatic cancer	0.000335	0.000806	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—pancreatic cancer	0.000334	0.000805	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—pancreatic cancer	0.000334	0.000804	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—pancreatic cancer	0.00033	0.000794	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—pancreatic cancer	0.000328	0.00079	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000328	0.000789	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—pancreatic cancer	0.000327	0.000788	CcSEcCtD
Oxymorphone—Pain—Epirubicin—pancreatic cancer	0.000325	0.000781	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—pancreatic cancer	0.000325	0.000781	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—pancreatic cancer	0.000318	0.000765	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000313	0.000754	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000313	0.000753	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—pancreatic cancer	0.000312	0.000751	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00031	0.000747	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000309	0.000744	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000305	0.000735	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000303	0.00073	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—pancreatic cancer	0.000303	0.000729	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—pancreatic cancer	0.000302	0.000726	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—pancreatic cancer	0.0003	0.000723	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—pancreatic cancer	0.0003	0.000723	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—pancreatic cancer	0.0003	0.000722	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—pancreatic cancer	0.0003	0.000722	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000289	0.000697	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000287	0.000691	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—pancreatic cancer	0.00028	0.000673	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—pancreatic cancer	0.000279	0.000672	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000278	0.000668	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000278	0.000668	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—pancreatic cancer	0.000272	0.000655	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—pancreatic cancer	0.000269	0.000646	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—pancreatic cancer	0.00026	0.000625	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000259	0.000623	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—pancreatic cancer	0.000252	0.000606	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—pancreatic cancer	0.000251	0.000604	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—pancreatic cancer	0.000248	0.000598	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—pancreatic cancer	0.000241	0.000581	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—pancreatic cancer	0.00024	0.000578	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—pancreatic cancer	0.000239	0.000575	CcSEcCtD
Oxymorphone—Headache—Epirubicin—pancreatic cancer	0.000238	0.000572	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—pancreatic cancer	0.000232	0.000559	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—pancreatic cancer	0.000225	0.000543	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—pancreatic cancer	0.000223	0.000537	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—pancreatic cancer	0.000221	0.000532	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—pancreatic cancer	0.00022	0.00053	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—pancreatic cancer	0.000209	0.000502	CcSEcCtD
Oxymorphone—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000146	0.000651	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000145	0.000649	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.000145	0.000647	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000144	0.000645	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000142	0.000635	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.000142	0.000633	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.00014	0.000626	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.00014	0.000626	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.00014	0.000624	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.000137	0.00061	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.000137	0.00061	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000136	0.000606	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.000134	0.000597	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.000134	0.000597	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.000133	0.000595	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000133	0.000593	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000133	0.000593	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000132	0.000591	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000132	0.000588	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.00013	0.000582	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.00013	0.000582	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.00013	0.000581	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000129	0.000577	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000128	0.000572	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000128	0.000571	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.000126	0.000564	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.000126	0.000564	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.000125	0.000558	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.000124	0.000555	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000123	0.00055	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000122	0.000547	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.000118	0.000529	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.000118	0.000529	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000117	0.000522	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000116	0.000518	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.000115	0.000516	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.000115	0.000515	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000114	0.000509	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000113	0.000505	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000113	0.000504	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000113	0.000503	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000111	0.000495	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000111	0.000495	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.00011	0.000492	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.00011	0.000492	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.00011	0.000491	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.000108	0.000484	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.000107	0.000476	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000105	0.000469	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000103	0.000462	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000103	0.000462	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.000103	0.00046	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000101	0.000452	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.0001	0.000447	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.99e-05	0.000446	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	9.91e-05	0.000443	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SHH—pancreatic cancer	9.87e-05	0.000441	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	9.87e-05	0.000441	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	9.82e-05	0.000439	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	9.81e-05	0.000438	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	9.75e-05	0.000435	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STK11—pancreatic cancer	9.68e-05	0.000432	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PRSS1—pancreatic cancer	9.52e-05	0.000425	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	9.36e-05	0.000418	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	9.36e-05	0.000418	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	9.34e-05	0.000417	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	9.09e-05	0.000406	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.07e-05	0.000405	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GCG—pancreatic cancer	9.03e-05	0.000403	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.78e-05	0.000392	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.73e-05	0.00039	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	8.61e-05	0.000385	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SST—pancreatic cancer	8.56e-05	0.000382	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STK11—pancreatic cancer	8.49e-05	0.000379	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	8.48e-05	0.000379	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.44e-05	0.000377	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.39e-05	0.000375	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	8.37e-05	0.000374	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	8.34e-05	0.000373	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HES1—pancreatic cancer	8.28e-05	0.00037	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ARG2—pancreatic cancer	8.26e-05	0.000369	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.97e-05	0.000356	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.93e-05	0.000354	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	7.9e-05	0.000353	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	7.66e-05	0.000342	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.65e-05	0.000342	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GCG—pancreatic cancer	7.63e-05	0.000341	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	7.62e-05	0.00034	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	7.43e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.42e-05	0.000331	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.35e-05	0.000328	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	7.28e-05	0.000325	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HES1—pancreatic cancer	7.26e-05	0.000324	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TERT—pancreatic cancer	7.25e-05	0.000324	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TYMP—pancreatic cancer	7.22e-05	0.000322	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STK11—pancreatic cancer	7.17e-05	0.00032	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.95e-05	0.00031	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	6.94e-05	0.00031	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	6.92e-05	0.000309	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOE—pancreatic cancer	6.77e-05	0.000302	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	6.74e-05	0.000301	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	6.68e-05	0.000298	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KDR—pancreatic cancer	6.63e-05	0.000296	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.47e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TERT—pancreatic cancer	6.36e-05	0.000284	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	6.31e-05	0.000282	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	6.28e-05	0.000281	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	6.25e-05	0.000279	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	6.23e-05	0.000278	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	6.22e-05	0.000278	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HES1—pancreatic cancer	6.13e-05	0.000274	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	6.11e-05	0.000273	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	6.11e-05	0.000273	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	6.08e-05	0.000272	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	6.07e-05	0.000271	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGF—pancreatic cancer	6.04e-05	0.00027	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOE—pancreatic cancer	5.94e-05	0.000265	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	5.87e-05	0.000262	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	5.82e-05	0.00026	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KDR—pancreatic cancer	5.82e-05	0.00026	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.72e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	5.64e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	5.57e-05	0.000249	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	5.53e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	5.48e-05	0.000245	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	5.43e-05	0.000243	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.4e-05	0.000241	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TERT—pancreatic cancer	5.37e-05	0.00024	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	5.37e-05	0.00024	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	5.36e-05	0.000239	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	5.36e-05	0.000239	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.32e-05	0.000238	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGF—pancreatic cancer	5.3e-05	0.000237	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	5.26e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	5.14e-05	0.00023	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	5.13e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOE—pancreatic cancer	5.02e-05	0.000224	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—pancreatic cancer	4.92e-05	0.00022	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	4.88e-05	0.000218	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.83e-05	0.000216	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.72e-05	0.000211	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	4.71e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	4.68e-05	0.000209	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	4.68e-05	0.000209	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.66e-05	0.000208	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	4.63e-05	0.000207	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	4.61e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	4.53e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	4.53e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	4.5e-05	0.000201	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGF—pancreatic cancer	4.48e-05	0.0002	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	4.47e-05	0.0002	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	4.35e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	4.31e-05	0.000192	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.24e-05	0.000189	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD44—pancreatic cancer	4.21e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	4.19e-05	0.000187	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	4.15e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	4.13e-05	0.000184	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	4.11e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	4.07e-05	0.000182	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	4.05e-05	0.000181	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCG—pancreatic cancer	4.03e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	3.98e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	3.95e-05	0.000176	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	3.94e-05	0.000176	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.94e-05	0.000176	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	3.92e-05	0.000175	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	3.9e-05	0.000174	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	3.81e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.8e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—STK11—pancreatic cancer	3.79e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	3.78e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SRC—pancreatic cancer	3.75e-05	0.000168	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.74e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	3.68e-05	0.000164	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	3.65e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	3.64e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	3.62e-05	0.000162	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	3.61e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.58e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	3.57e-05	0.000159	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.55e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	3.55e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.47e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	3.46e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—pancreatic cancer	3.36e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	3.35e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	3.33e-05	0.000149	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	3.31e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SRC—pancreatic cancer	3.29e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	3.29e-05	0.000147	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.26e-05	0.000146	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	3.22e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	3.2e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	3.19e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	3.17e-05	0.000142	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	3.16e-05	0.000141	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	3.11e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	3.11e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.08e-05	0.000137	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	3.02e-05	0.000135	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	3e-05	0.000134	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—pancreatic cancer	2.95e-05	0.000132	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	2.94e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	2.92e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	2.88e-05	0.000129	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	2.85e-05	0.000127	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SRC—pancreatic cancer	2.78e-05	0.000124	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—pancreatic cancer	2.76e-05	0.000123	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD44—pancreatic cancer	2.75e-05	0.000123	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	2.72e-05	0.000122	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.71e-05	0.000121	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	2.68e-05	0.00012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	2.67e-05	0.000119	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOE—pancreatic cancer	2.65e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	2.64e-05	0.000118	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCG—pancreatic cancer	2.64e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	2.5e-05	0.000112	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—pancreatic cancer	2.49e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.49e-05	0.000111	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—STK11—pancreatic cancer	2.48e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	2.44e-05	0.000109	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—pancreatic cancer	2.42e-05	0.000108	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.39e-05	0.000107	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	2.33e-05	0.000104	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	2.32e-05	0.000103	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.31e-05	0.000103	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	2.3e-05	0.000103	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.13e-05	9.52e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.12e-05	9.45e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.1e-05	9.4e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—pancreatic cancer	2.05e-05	9.14e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	2.04e-05	9.13e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	1.96e-05	8.74e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.83e-05	8.19e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.82e-05	8.12e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOE—pancreatic cancer	1.73e-05	7.75e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	1.73e-05	7.72e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.59e-05	7.08e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.57e-05	6.99e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.51e-05	6.75e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.38e-05	6.15e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.2e-05	5.36e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.19e-05	5.31e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.12e-05	4.99e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.04e-05	4.63e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.13e-06	4.08e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.31e-06	3.27e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.97e-06	2.67e-05	CbGpPWpGaD
